Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Morley

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Isosteric replacements for benzothiazoles and optimisation to potent Cathepsin K inhibitors free from hERG channel inhibitionAlexander G Dossetter, Jonathan Bowyer, Calum R Cook, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2009
Dipeptidyl nitrile inhibitors of Cathepsin LNabil Asaad, Paul A Bethel, Michelle D Coulson, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2006
Novel thienopyrrole glycogen phosphorylase inhibitors: synthesis, in vitro SAR and crystallographic studiesPaul R O Whittamore, Matthew S Addie, Stuart N L Bennett, et al.
Journal of Medicinal Chemistry|September 19, 2012
Pharmacokinetic benefits of 3,4-dimethoxy substitution of a phenyl ring and design of isosteres yielding orally available cathepsin K inhibitorsJames J Crawford, Peter W Kenny, Jonathan Bowyer, et al.
Journal of Medicinal Chemistry|June 30, 2012
(1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritisAlexander G Dossetter, Howard Beeley, Jonathan Bowyer, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Isosteric replacements for benzothiazoles and optimisation to potent Cathepsin K inhibitors free from hERG channel inhibitionAlexander G Dossetter, Jonathan Bowyer, Calum R Cook, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2009
Dipeptidyl nitrile inhibitors of Cathepsin LNabil Asaad, Paul A Bethel, Michelle D Coulson, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2006
Novel thienopyrrole glycogen phosphorylase inhibitors: synthesis, in vitro SAR and crystallographic studiesPaul R O Whittamore, Matthew S Addie, Stuart N L Bennett, et al.
Journal of Medicinal Chemistry|September 19, 2012
Pharmacokinetic benefits of 3,4-dimethoxy substitution of a phenyl ring and design of isosteres yielding orally available cathepsin K inhibitorsJames J Crawford, Peter W Kenny, Jonathan Bowyer, et al.
Journal of Medicinal Chemistry|June 30, 2012
(1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritisAlexander G Dossetter, Howard Beeley, Jonathan Bowyer, et al.
Pageof 2